anmelden
BX Swiss TOP 30 CHF
1.396,39
PKT
+6,29
PKT
+0,45
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.04.22 | Nestlé Buy | UBS AG | |
| 21.04.22 | Nestlé Sector Perform | RBC Capital Markets | |
| 21.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 21.04.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 20.04.22 | Swiss Re Overweight | Barclays Capital | |
| 20.04.22 | UBS Hold | Jefferies & Company Inc. | |
| 20.04.22 | UBS Sector Perform | RBC Capital Markets | |
| 20.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Buy | Jefferies & Company Inc. | |
| 19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 19.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.04.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Sell | UBS AG | |
| 19.04.22 | Holcim Equal Weight | Barclays Capital | |
| 14.04.22 | Holcim Outperform | Credit Suisse Group | |
| 14.04.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 14.04.22 | UBS Hold | Deutsche Bank AG | |
| 14.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 13.04.22 | UBS Neutral | UBS AG | |
| 13.04.22 | Givaudan Neutral | UBS AG | |
| 13.04.22 | Givaudan Hold | Deutsche Bank AG | |
| 13.04.22 | Roche Equal-weight | Morgan Stanley | |
| 13.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 13.04.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 12.04.22 | Givaudan Underweight | Barclays Capital | |
| 12.04.22 | Givaudan Add | Baader Bank | |
| 12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 11.04.22 | Richemont Outperform | RBC Capital Markets | |
| 11.04.22 | Richemont Buy | Jefferies & Company Inc. | |
| 08.04.22 | Novartis Neutral | UBS AG | |
| 07.04.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 07.04.22 | Swiss Re Sell | UBS AG |